Demo home | NDF News	You are logged in as: Demo User

Latest 30 News Items

Date Added Title 2006-03-07 Jerini reveals Phase III update for Icatibant in Hereditary Angioedema 2006-03-07 Verus reveals data for Epinephrine in Anaphylaxis 2006-03-06 Dynavax reveals Phase II/III data for Tolamba 2006-03-06 ZLB Behring reveals data for C1 Inhibitor in HAE 2006-03-06 ZLB Behring reveals Phase III data for Vivaglobin 2006-03-06 Altana reveals Phase III data for Ciclesonide 2006-03-02 Dynavax updates on Tolamba development programme 2006-02-17 Altana has revealed that Alvesco receives additional approval in Asthma in EU 2006-02-13 Pharmaxis receives marketing recommendation from ADEC for Aridol 2006-02-07 Pharmaxis enters distribution agreement for Aridol 2006-01-19 Dynavax reveals Phase II/III data for Tolamba study 2006-01-16 MediciNova receives notice of allowance for two patent applications for MN 001 2005-12-14 U.S. Phase III Aridol Trial Enrols First Patient 2005-12-14 MediciNova Announces Positive Clinical Results With MN-001 in a Phase II Asthma Trial 2005-12-13 Merck makes US label change for Singulair 2005-11-09 Sanofi Aventis reports results of long-term use of Alvesco 2005-11-08 Dynavax's Tolamba shows safety in Phase I study 2005-11-08 Pulmicort Respules well tolerated in long-term use 2005-10-27 Xolair approved by EC 2005-10-18 Topigen initiates Phase II trial of ASM 8 2005-09-27 Dynavax introduces Tolamba and Heplisav brand names for ragweed allergy and hepatitis B vaccines 2005-09-27 AstraZeneca submits US NDA for Symbicort for treatment of Asthma 2005-09-22 LAB International completes Phase I trial for LAB CGRP 2005-09-14 Alvesco did not affect HPA-Axis function in moderate-to-severe persistent asthma 2005-09-12 King Pharmaceuticals and Inyx enter into strategic alliance 2005-09-08 MediciNova completes enrolment of Phase II study for oral asthma treatment 2005-09-08 SkyePharma launches Foradil Certihaler in Germany 2005-08-19 Positive single-season Phase I data on Dynavax's AIC ragweed allergy therapy 2005-08-02 BioMarin files New Drug Application for Orapred ODT 2005-08-02 MediciNova initiates a Phase II trial with MN 166 in MS